These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29263041)

  • 1. Enzyme Kinetic Assay to Measure the Activity of Tumor M2 Pyruvate Kinase in Breast Cancer Patients.
    Guan M; Tong Y; Liu X; Dong D; Zhou Y
    Ann Clin Lab Sci; 2017 Nov; 47(6):676-686. PubMed ID: 29263041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer.
    Lüftner D; Mazurek S; Henschke P; Mesterharm J; Schildhauer S; Geppert R; Wernecke KD; Possinger K
    Anticancer Res; 2003; 23(2A):991-7. PubMed ID: 12820337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients.
    El-Abd E; El-Sheikh M; Zaky S; Fayed W; El-Zoghby S
    Cancer Biomark; 2017 Aug; 20(2):123-133. PubMed ID: 28869444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer.
    Li L; Xu Y; Wang Y; Zhang Q; Wang Y; Xu C
    Technol Cancer Res Treat; 2024; 23():15330338241265983. PubMed ID: 39043046
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma.
    Ugurel S; Bell N; Sucker A; Zimpfer A; Rittgen W; Schadendorf D
    Int J Cancer; 2005 Dec; 117(5):825-30. PubMed ID: 15957165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
    Ervens J; Fuchs H; Niemann VT; Hoffmeister B
    J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase type tumor M2 in urological malignancies.
    Hegele A; Varga Z; Kosche B; Stief T; Heidenreich A; Hofmann R
    Urol Int; 2003; 70(1):55-8. PubMed ID: 12566817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer.
    Xu C; Liu W; Li L; Wang Y; Yuan Q
    J Cell Mol Med; 2021 Aug; 25(15):7335-7341. PubMed ID: 34255923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.
    Nisman B; Yutkin V; Nechushtan H; Gofrit ON; Peretz T; Gronowitz S; Pode D
    Urology; 2010 Aug; 76(2):513.e1-6. PubMed ID: 20573390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma.
    Roigas J; Deger S; Schroeder J; Wille A; Turk I; Brux B; Jung K; Schnorr D; Loening SA
    Urol Res; 2003 Dec; 31(6):358-62. PubMed ID: 14513300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?
    Varga Z; Hegele A; Stief T; Heidenreich A; Hofmann R
    Urol Res; 2002 May; 30(2):122-5. PubMed ID: 12086017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
    Zhang T; Liu W; Li L; Jue Z; Xu C
    BMC Pulm Med; 2022 Aug; 22(1):307. PubMed ID: 35948914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer.
    Mulder SA; van Leerdam ME; van Vuuren AJ; Francke J; van Toorenenbergen AW; Kuipers EJ; Ouwendijk RJ
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):878-82. PubMed ID: 17873612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions.
    Cerwenka H; Aigner R; Bacher H; Werkgartner G; el-Shabrawi A; Quehenberger F; Mischinger HJ
    Anticancer Res; 1999; 19(1B):849-51. PubMed ID: 10216504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer.
    Oremek GM; Eigenbrodt E; Rädle J; Zeuzem S; Seiffert UB
    Anticancer Res; 1997; 17(4B):3031-3. PubMed ID: 9329593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the diagnostic and prognostic value of serum TuM2-PK, NSE, and ProGRP in small cell lung cancer.
    Li L; Zhang Q; Wang Y; Xu C
    J Clin Lab Anal; 2023 Apr; 37(7):e24865. PubMed ID: 37088873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis.
    Kumar Y; Gurusamy K; Pamecha V; Davidson BR
    Pancreas; 2007 Aug; 35(2):114-9. PubMed ID: 17632316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer].
    Kim CW; Kim JI; Park SH; Han JY; Kim JK; Chung KW; Sun HS
    Korean J Gastroenterol; 2003 Nov; 42(5):387-93. PubMed ID: 14646575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.